Skip to main content

Table 3 League of each treatment regimen on drug-related adverse events

From: Prokinetics for the treatment of functional dyspepsia: an updated systematic review and network meta-analysis

Cinitapride

1.00 (0.47, 2.07)

0.04 (0, 6421.09)

0.37 (0.03, 3.67)

0.45 (0.04, 4.32)

1.00 (0.48, 2.11)

Domperidone

0.04 (0, 6038.07)

0.38 (0.03, 3.38)

0.46 (0.04, 4.02)

27.34 (0, 148817954.82)

27.3 (0, 143585383.88)

Itopride

10.25 (0, 60877502.63)

12.29 (0, 72591299.15)

2.67 (0.27, 32.42)

2.64 (0.3, 29.04)

0.10 (0, 19807.02)

Acotiamide

1.20 (0.91, 1.57)

2.23 (0.23, 27)

2.19 (0.25, 23.8)

0.08 (0, 16299.35)

0.83 (0.64, 1.09)

Placebo

  1. Notes: Odds ratio with 95% credible interval is described in each column. Prokinetic agent in the top left means better efficacy and statistical validity is guaranteed when the 95% credible interval does not include 1